Why the study?
Because eGFR reliability may be affected by body size, the study aimed to clarify whether individual BSA adjustment of eGFR enhances the relationship with kidney and vascular functions in the general healthy Japanese population.
Does BSA-adjusted eGFR improve the prediction of high arterial stiffness (CAVI ≥ 9.0) compared to conventional eGFR in a healthy general population?
Does BSA-adjusted eGFR improve the prediction of high arterial stiffness (CAVI ≥ 9.0) compared to conventional eGFR in a healthy general population?
Adjusting eGFR for individual body surface area provides a more accurate assessment of kidney function and its association with arterial stiffness (CAVI) than conventional eGFR, potentially improving cardiovascular risk stratification.
AIM: , its reliability may be affected by body size. We aimed to clarify whether the individual's BSA adjustment of eGFR enhances the relationship with kidney and vascular functions in the general healthy Japanese population. METHODS: . Arterial stiffness was assessed by the cardio-ankle vascular index (CAVI), and a high CAVI was defined as CAVI ≥ 9.0. RESULTS: Compared with the eGFR, the BSA-adjusted eGFR showed higher values in males in their 20s to 50s and lower values in females of all ages. The BSA-adjusted eGFR showed a stronger negative correlation with the CAVI than the eGFR (R: -0.444 vs. -0.388 in males, -0.449 vs. -0.416 in females). In a receiver-operating characteristic curve analysis, the discriminative power for a high CAVI was stronger for the BSA-adjusted eGFR than for the eGFR (area under the curve: 0.776 vs. 0.723 in males, 0.757 vs. 0.716 in females). The upper tertile of the BSA-adjusted eGFR showed higher odds ratios for a high CAVI than that of the eGFR in both sexes, after adjusting for covariates. CONCLUSIONS: The BSA-adjusted eGFR appropriately assesses the kidney function according to differences in sex, age and body size. Furthermore, a CAVI analysis suggested that the BSA-adjusted eGFR might facilitate the achievement of more precise preventive care for CVD.
No takes yet. Share an insight, caveat, or question.
Nagayama et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Women and heart diseaseMore from Journal of Atherosclerosis and Thrombosis